Pregnancy and Liver Function
Biochemical Changes
- Mild elevations in alkaline phosphatase levels are common during the second and third trimester of pregnancy 1
- The American Association for the Study of Liver Diseases and the European Association for the Study of the Liver provide guidelines for the management of liver disease, including alcoholic liver disease and autoimmune hepatitis 2, 3, 4
Evaluation and Diagnosis
- Patients with abnormal liver function tests should be assessed for symptoms of liver disease, such as jaundice, fatigue, and abdominal pain, and evaluated for risk factors for viral hepatitis, non-alcoholic fatty liver disease, and alcohol-related liver disease, as recommended by the European Association for the Study of the Liver 3
- A complete liver panel, including AST, ALT, alkaline phosphatase, GGT, total and direct bilirubin, is recommended for evaluation of abnormal liver enzymes, as suggested by the American Gastroenterological Association 5
- Viral hepatitis screening should include Hepatitis B surface antigen (HBsAg), Hepatitis B core antibody (anti-HBc), Hepatitis C antibody (with reflex RNA testing if positive), and consideration of Hepatitis A IgM in acute presentations, as recommended by the European Association for the Study of the Liver 6, 7
- Abdominal ultrasound is recommended as the first-line imaging test to assess for biliary obstruction, liver lesions, or other structural abnormalities, and CT or MRCP should be considered if ultrasound is inconclusive, as suggested by the American College of Radiology 8
The following table summarizes the interpretation of liver function tests:
Elevation Description <2× upper limit of normal often non-specific, may not indicate significant liver disease 2-5× upper limit of normal warrants further investigation >5× upper limit of normal suggests significant liver injury requiring prompt evaluation >20× upper limit of normal suggests acute severe liver injury (viral, drug-induced, ischemic)
Treatment and Management
- Immediate alcohol abstinence is the cornerstone of therapy for alcoholic liver disease, and consideration of referral for alcohol use disorder treatment is recommended, as suggested by the Journal of Hepatology society and the American Association for the Study of Liver Diseases 9, 10, 11
- Treatment with corticosteroids (prednisone) and/or azathioprine is recommended, with initial therapy consisting of prednisone (30-60 mg daily) alone or prednisone (30 mg daily) with azathioprine (150 mg daily), as recommended by the American Association for the Study of Liver Diseases 4
- The minimum treatment duration is 24 months before considering withdrawal, and treatment should be continued until normalization of AST/ALT, total bilirubin, and IgG levels, as recommended by the American Association for the Study of Liver Diseases 4
The following table summarizes the guidelines for medications with potential hepatotoxicity:
Condition Description ALT/AST >3x ULN adjust dose or discontinue medication ALT/AST >5x ULN discontinue medication and consider referral to hepatology Lifestyle modifications, including a Mediterranean diet, regular exercise, and weight loss if overweight/obese, are recommended for patients with elevated liver enzymes, as suggested by the American Heart Association, the European Association for the Study of the Liver, and other guideline societies 14, 15, 3, 8, 16, 17, 18, 19, 20, 21, 11
Referral and Follow-up
The American Association for the Study of Liver Diseases recommends expediting evaluation or considering referral to hepatology if ALT/AST increases to >5× ULN, ALT/AST >3× ULN with total bilirubin ≥2× ULN, persistent elevation >6 months despite interventions, or development of symptoms such as jaundice, abdominal pain, or fatigue, with specific conditions requiring referral to hepatology:
Condition Description Persistent elevation >6 months despite interventions Suspected autoimmune hepatitis requires histological confirmation Conflicting clinical, laboratory, and imaging findings requires further evaluation Development of jaundice, ALT elevation >5× ULN, elevated bilirubin with elevated transaminases, or signs of hepatic decompensation requires immediate attention Absolute indications for delay or referral include:
Condition Description ALT/AST >20× ULN absolute indication for delay Evidence of acute liver failure absolute indication for delay Acute viral hepatitis absolute indication for delay Decompensated cirrhosis absolute indication for delay - Annual monitoring of liver enzymes is reasonable for long-term follow-up, as suggested by the European Heart Journal 24
- If liver enzyme elevation persists for more than 1-2 weeks, evaluate for alternative causes and consider initiating oral corticosteroids, as recommended by the Journal of Autoimmunity 25
- If immune-mediated liver injury is suspected, withhold statin therapy and initiate corticosteroid therapy, as recommended by the Journal of Autoimmunity 25